Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 28

1.

Reversible, Position-Dependent Midbrain Compression in a Patient with Spontaneous Intracranial Hypotension.

Williams JR, Buckley R, Oushy S, Ruzevick J, Chesnut RM.

World Neurosurg. 2019 Jul 16;130:293-297. doi: 10.1016/j.wneu.2019.07.088. [Epub ahead of print]

PMID:
31323415
2.

Intra- and Perioperative Complications Associated with Endoscopic Spine Surgery: A Multi-Institutional Study.

Sen RD, White-Dzuro G, Ruzevick J, Kim CW, Witt JP, Telfeian AE, Wang MY, Hofstetter CP.

World Neurosurg. 2018 Dec;120:e1054-e1060. doi: 10.1016/j.wneu.2018.09.009. Epub 2018 Sep 11.

PMID:
30213674
3.

Tumor Treating Fields in Neuro-Oncological Practice.

Mrugala MM, Ruzevick J, Zlomanczuk P, Lukas RV.

Curr Oncol Rep. 2017 Aug;19(8):53. doi: 10.1007/s11912-017-0611-8. Review.

PMID:
28664468
4.

Clival paragangliomas: a report of two cases involving the midline skull base and review of the literature.

Ruzevick J, Koh EK, Gonzalez-Cuyar LF, Cimino PJ, Moe K, Wright LA, Failor R, Ferreira M.

J Neurooncol. 2017 May;132(3):473-478. doi: 10.1007/s11060-017-2396-x. Epub 2017 Mar 16. Review.

PMID:
28299533
5.

Erratum to: PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment.

Mathios D, Ruzevick J, Jackson CM, Xu H, Shah SR, Taube JM, Burger PC, McCarthy EF, Quinones-Hinojosa A, Pardoll DM, Lim M.

J Neurooncol. 2016 May;128(1):183. doi: 10.1007/s11060-016-2130-0. No abstract available.

PMID:
27161248
6.

Immune Checkpoint Modulators: An Emerging Antiglioma Armamentarium.

Kim ES, Kim JE, Patel MA, Mangraviti A, Ruzevick J, Lim M.

J Immunol Res. 2016;2016:4683607. doi: 10.1155/2016/4683607. Epub 2016 Jan 4. Review.

7.

Pituitary adenomas: historical perspective, surgical management and future directions.

Theodros D, Patel M, Ruzevick J, Lim M, Bettegowda C.

CNS Oncol. 2015;4(6):411-29. doi: 10.2217/cns.15.21. Epub 2015 Oct 26. Review.

8.

Systemic Tolerance Mediated by Melanoma Brain Tumors Is Reversible by Radiotherapy and Vaccination.

Jackson CM, Kochel CM, Nirschl CJ, Durham NM, Ruzevick J, Alme A, Francica BJ, Elias J, Daniels A, Dubensky TW Jr, Lauer P, Brockstedt DG, Baxi EG, Calabresi PA, Taube JM, Pardo CA, Brem H, Pardoll DM, Lim M, Drake CG.

Clin Cancer Res. 2016 Mar 1;22(5):1161-72. doi: 10.1158/1078-0432.CCR-15-1516. Epub 2015 Oct 21.

9.

Technical note: Orbitozygomatic craniotomy using an ultrasonic osteotome for precise osteotomies.

Ruzevick J, Raza SM, Recinos PF, Chaichana K, Pradilla G, Kim JE, Olivi A, Weingart J, Evans J, Quinones-Hinojosa A, Lim M.

Clin Neurol Neurosurg. 2015 Jul;134:24-7. doi: 10.1016/j.clineuro.2015.04.005. Epub 2015 Apr 13.

10.

Intraoperative hypertensive crisis due to a catecholamine-secreting esthesioneuroblastoma.

Salmasi V, Schiavi A, Binder ZA, Ruzevick J, Orr BA, Burger PC, Ball DW, Blitz AM, Koch WM, Ishii M, Gallia GL.

Head Neck. 2015 Jun;37(6):E74-80. doi: 10.1002/hed.23907. Epub 2015 Apr 6. Review.

11.

PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment.

Mathios D, Ruzevick J, Jackson CM, Xu H, Shah SR, Taube JM, Burger PC, McCarthy EF, Quinones-Hinojosa A, Pardoll DM, Lim M.

J Neurooncol. 2015 Jan;121(2):251-9. doi: 10.1007/s11060-014-1637-5. Epub 2014 Oct 28. Erratum in: J Neurooncol. 2016 May;128(1):183.

12.

The future of glioblastoma therapy: synergism of standard of care and immunotherapy.

Patel MA, Kim JE, Ruzevick J, Li G, Lim M.

Cancers (Basel). 2014 Sep 29;6(4):1953-85. doi: 10.3390/cancers6041953. Review.

13.

Focal radiation therapy combined with 4-1BB activation and CTLA-4 blockade yields long-term survival and a protective antigen-specific memory response in a murine glioma model.

Belcaid Z, Phallen JA, Zeng J, See AP, Mathios D, Gottschalk C, Nicholas S, Kellett M, Ruzevick J, Jackson C, Albesiano E, Durham NM, Ye X, Tran PT, Tyler B, Wong JW, Brem H, Pardoll DM, Drake CG, Lim M.

PLoS One. 2014 Jul 11;9(7):e101764. doi: 10.1371/journal.pone.0101764. eCollection 2014.

14.

Extravascular optical coherence tomography: evaluation of carotid atherosclerosis and pravastatin therapy.

Wicks RT, Huang Y, Zhang K, Zhao M, Tyler BM, Suk I, Hwang L, Ruzevick J, Jallo G, Brem H, Pradilla G, Kang JU.

Stroke. 2014 Apr;45(4):1123-1130. doi: 10.1161/STROKEAHA.113.002970. Epub 2014 Mar 13.

15.

STAT3 Activation in Glioblastoma: Biochemical and Therapeutic Implications.

Kim JE, Patel M, Ruzevick J, Jackson CM, Lim M.

Cancers (Basel). 2014 Feb 10;6(1):376-95. doi: 10.3390/cancers6010376.

16.

A Patient with HIV Treated with Ipilimumab and Stereotactic Radiosurgery for Melanoma Metastases to the Brain.

Ruzevick J, Nicholas S, Redmond K, Kleinberg L, Lipson EJ, Lim M.

Case Rep Oncol Med. 2013;2013:946392. doi: 10.1155/2013/946392. Epub 2013 Dec 8.

17.

Erlotinib inhibits growth of a patient-derived chordoma xenograft.

Siu IM, Ruzevick J, Zhao Q, Connis N, Jiao Y, Bettegowda C, Xia X, Burger PC, Hann CL, Gallia GL.

PLoS One. 2013 Nov 15;8(11):e78895. doi: 10.1371/journal.pone.0078895. eCollection 2013.

18.

Imaging changes following stereotactic radiosurgery for metastatic intracranial tumors: differentiating pseudoprogression from tumor progression and its effect on clinical practice.

Ruzevick J, Kleinberg L, Rigamonti D.

Neurosurg Rev. 2014 Apr;37(2):193-201; discussion 201. doi: 10.1007/s10143-013-0504-8. Epub 2013 Nov 15. Review.

19.

A glutamate receptor antagonist, S-4-carboxyphenylglycine (S-4-CPG), inhibits vasospasm after subarachnoid hemorrhage in haptoglobin 2-2 mice [corrected].

Garzon-Muvdi T, Pradilla G, Ruzevick JJ, Bender M, Edwards L, Grossman R, Zhao M, Rudek MA, Riggins G, Levy A, Tamargo RJ.

Neurosurgery. 2013 Oct;73(4):719-28; discussion 729. doi: 10.1227/NEU.0000000000000080. Erratum in: Neurosurgery. 2013 Dec;73(6):E1098.

20.

Current trends in glioblastoma multiforme treatment: radiation therapy and immune checkpoint inhibitors.

Nicholas S, Mathios D, Ruzevick J, Jackson C, Yang I, Lim M.

Brain Tumor Res Treat. 2013 Apr;1(1):2-8. doi: 10.14791/btrt.2013.1.1.2. Epub 2013 Apr 30. Review.

Supplemental Content

Loading ...
Support Center